Redirect Notice
The previous page is sending you to
http://www.agenziafarmaco.gov.it/content/comunicazione-aifa-aggiornamento-sul-rischio-di-febbre-e-convulsioni-febbrili-dopo-somminist
.
If you do not want to visit that page, you can
return to the previous page
.